Plain-English translation of NCT07251257 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a one-year study for seafarers who rely on insulin to manage their diabetes. You would wear a Dexcom G7 continuous glucose monitoring device, which measures your blood sugar automatically throughout the day and sends readings to your phone. The study aims to see how well this technology works for people whose jobs at sea make diabetes management especially challenging.
Seafarers face unique obstacles managing diabetes because of unpredictable schedules, limited access to medical care, and the physical demands of working on ships. This study wants to understand whether continuous glucose monitoring can help keep blood sugar stable and improve safety for people who work at sea.
You likely qualify if…
You likely don't qualify if…
You would wear the Dexcom G7 glucose monitor continuously for one year while working at sea and on land. You would use a smartphone app called Fishers Watch to record your blood sugar readings, any high or low blood sugar episodes, and your daily activities—the app sends you daily text reminders to log this information. The researchers will collect this data to understand how well the technology supports diabetes management for seafarers.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United Kingdom